Insulet Omnipod 5 insulin pump bests conventional delivery systems. Mar. 08, 2024 8:43 AM ET Insulet Corporation (PODD) Stock MDT, DXCM, TNDM By: Dulan Lokuwithana, SA News Editor 4 Comments.

Insulet Corporation PODD reported Q3 sales of $432.7 million, up 27.0%, or 25.1% in constant currency, beating the consensus of $414.383 million. Total Omnipod revenue of $422 million marked a ...

Insulet continues to see adoption of its Omnipod 5 pump—the device that represents Insulet's entrance into hybrid closed-loop technology that makes life easier by automating insulin delivery, or ...

ACTON, Mass., June 10, 2025--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible ...

The insulin pump market is projected to reach $14bn in the same period, as per GlobalData analysis. Insulet also secured label expansion for Omnipod 5 device from the FDA allowing for its use in ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its groundbreaking Omnipod ...

JOHOR BAHRU, Aug 14 (Bernama) -- United States-based medical device company Insulet Corporation’s new manufacturing facility in Johor Bahru will position the company strategically to stay ahead of the ...

Barbie now reflects real-life conditions. Mattel releases a Type 1 diabetes doll amid rising cases among UK girls and calls ...

ACTON, Mass., January 13, 2025--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today ...

Insulin pumps are wearable devices that people with diabetes use to deliver insulin. They are connected to a spot on your body and continuously give insulin for 2 to 4 days. An insulin pump is a ...